Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis

Published:2015-04-13 Issue:3 Volume:170 Page:356-366
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Adams Hugo J. A.¹,Nievelstein Rutger A. J.¹,Kwee Thomas C.¹

Affiliation:

1. Department of Radiology and Nuclear Medicine; University Medical Centre Utrecht; Utrecht the Netherlands

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13441/fullpdf

Reference32 articles.

1. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group;Barrington;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2014

2. Novel therapy for Hodgkin lymphoma;Batlevi;Hematology/the Education Program of the American Society of Hematology American Society of Hematology. Education Program,2013

3. 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma;Cerci;Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine,2010

4. Hodgkin lymphoma: protecting the victims of our success;Cheson;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2012

5. Revised response criteria for malignant lymphoma;Cheson;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2007

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment;Best Practice & Research Clinical Haematology;2023-12

2. Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma;Phenomics;2022-02-24

3. Role of PET/CT in initial evaluation of lymphoma patients;Egyptian Journal of Radiology and Nuclear Medicine;2021-12

4. Is thymus and activation-regulated chemokine a forgotten diagnostic and minimal residual disease marker in classical Hodgkin lymphoma?;memo - Magazine of European Medical Oncology;2021-10-04

5. In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detection;Med;2021-10